Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0001193125-26-144067

Chief Legal Officer sold 5,956 shares at $24.58 ($146,398)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bellon Christine Chief Legal Officer 2026-04-01 Sale 10b5-1 −5,956 $24.58 $146,398 109,711 D: show line 1 in the form
Open-market sales · 5,956 sh · avg $24.58 · $146,398
Loading xslF345X06/ownership.xml…